RadNet, Inc.
RDNTNasdaqHealthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.04B | $1.83B | $1.62B | $1.43B | $1.32B | $1.07B |
| Operating income | $62.0M | $104.6M | $98.7M | $46.4M | $82.6M | $35.7M |
| Net income | −$18.7M | $2.8M | $3.0M | $10.7M | $24.7M | −$14.8M |
| Total assets | $3.76B | $3.29B | $2.69B | $2.43B | $2.06B | $1.79B |
| Total liabilities | $2.40B | $2.15B | $1.88B | $1.94B | $1.71B | $1.53B |
| Equity | $1.09B | $902.3M | $630.7M | $333.0M | $228.9M | $165.7M |
| EPS (diluted) | $-0.25 | $0.04 | $0.05 | $0.17 | $0.46 | $-0.29 |
| Shares out. | 74.0M | 68.5M | 57.8M | 56.2M | 52.3M | 50.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 3.0%
- Net margin
- −0.9%
- Return on equity
- −1.7%
- Return on assets
- −0.5%
- Return on capital (ROCE)
- 2.0%
- Liabilities / assets
- 63.9%
- Debt / equity
- 2.20×
- Book value / share
- $14.72
- Revenue growth (YoY)
- 11.5%
- Net income growth (YoY)
- −767.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.28grey zone
- Accruals / assets
- −8.4%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 19, 2018
- NT 10-Qmissed a reporting deadline ↗Nov 12, 2013
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Price T Rowe Associates Inc /Md/Passive (13G)May 15, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Rtw Investments, LpPassive (13G)Feb 17, 2026
- Blackrock, Inc.Passive (13G)Oct 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Berger Howard GOfficer — President, CEO | May 5, 2026 | Option exercise | 25,992 | $18.64 |
| Sorensen Alma GregoryOfficer — Chief Strategy Officer | Mar 19, 2026 | Sell | 9,554 | $61.84 |
| Sorensen Alma GregoryOfficer — Chief Strategy Officer | Mar 16, 2026 | Tax withholding | 5,919 | $61.72 |
| Sorensen Alma GregoryOfficer — Chief Strategy Officer | Mar 10, 2026 | Option exercise | 3,742 | $0.00 |
| Patel MitalOfficer — EVP of Fin Planning, CAO | Mar 3, 2026 | Grant | 20,667 | $0.00 |
| Katz David JeffreyOfficer — EVP and Chief Legal Officer | Mar 3, 2026 | Grant | 19,289 | $0.00 |
| Wesdorp CornelisOfficer — Pres & CEO, Digital Health | Mar 3, 2026 | Grant | 20,330 | $0.00 |
| Stolper MarkOfficer — EVP, Chief Financial Officer | Mar 3, 2026 | Grant | 18,228 | $0.00 |
| Forthuber Stephen MOfficer — Pres & COO-Eastern Operations | Mar 3, 2026 | Grant | 22,045 | $0.00 |
| Hames Norman ROfficer — Pres and COO-West Operations | Mar 3, 2026 | Grant | 22,045 | $0.00 |
| Berger Howard GOfficer — President, CEO | Mar 3, 2026 | Grant | 124,001 | $0.00 |
| Murdock Michael NOfficer — EVP, Mergers and Acquisitions | Mar 3, 2026 | Grant | 6,613 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9.1M | 8.0 | -0.9% |
| Apr 30, 2026 | 9.1M | 10.8 | +3.7% |
| Apr 15, 2026 | 8.8M | 13.3 | +1.7% |
| Mar 31, 2026 | 8.7M | 10.6 | +4.2% |
| Mar 13, 2026 | 8.3M | 7.7 | +7.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 11, 2026
- Results of operationsMar 2, 2026
- Regulation FD disclosureMar 2, 2026
- Other material eventJan 30, 2026
- Director / officer change · Regulation FD disclosureJan 9, 2026
- Other material eventDec 4, 2025
- Results of operationsNov 10, 2025
- Other material eventOct 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13GMay 15, 2026
- 10-QMay 11, 2026
- 8-KCURREMT REPORTMay 11, 2026
- 4May 6, 2026
- SCHEDULE 13GApr 29, 2026
- ARSANNUAL REPORTApr 20, 2026
- DEFA14AFORM DEFA 14AApr 20, 2026
- DEF 14ADEFINITIVE PROXY STATEMENTApr 20, 2026
- SCHEDULE 13G/AMar 27, 2026
- 4Mar 23, 2026
- 144Mar 19, 2026
- 144Mar 18, 2026
- 4Mar 18, 2026
- 144Mar 18, 2026
- 4Mar 12, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.